Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Buckner

Showing results (481-490 of 525) with videos related to

Pageof 53
Sort By:
Bone Marrow Transplantation|July 1, 1995
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokineticsJ T Slattery, J E Sanders, C D Buckner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experienceJ E Anderson, M R Litzow, F R Appelbaum, et al.
Blood|December 1, 1988
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission durationP J Martin, R A Clift, L D Fisher, et al.
Experimental Hematology|October 1, 1985
Marrow harvesting for autologous marrow transplantationN R Jin, R S Hill, F B Petersen, et al.
Bone Marrow Transplantation|July 1, 1992
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I studyF B Petersen, C D Buckner, F R Appelbaum, et al.
Blood|September 1, 1984
Marrow harvesting from normal donorsC D Buckner, R A Clift, J E Sanders, et al.
Transplantation|November 1, 1983
Mycobacterial infections in marrow transplant patientsR M Navari, K M Sullivan, S C Springmeyer, et al.
Lancet (London, England)|September 18, 1982
Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantationR A Clift, C D Buckner, E D Thomas, et al.
Blood|April 15, 1991
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastomaR J Berenson, W I Bensinger, R S Hill, et al.
Bone Marrow Transplantation|March 1, 1997
Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II studyN Robinson, M C Benyunes, J A Thompson, et al.
Pageof 53

Showing results (481-490 of 525) with videos related to

Sort By:
Pageof 53
Bone Marrow Transplantation|July 1, 1995
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokineticsJ T Slattery, J E Sanders, C D Buckner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experienceJ E Anderson, M R Litzow, F R Appelbaum, et al.
Blood|December 1, 1988
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission durationP J Martin, R A Clift, L D Fisher, et al.
Experimental Hematology|October 1, 1985
Marrow harvesting for autologous marrow transplantationN R Jin, R S Hill, F B Petersen, et al.
Bone Marrow Transplantation|July 1, 1992
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I studyF B Petersen, C D Buckner, F R Appelbaum, et al.
Blood|September 1, 1984
Marrow harvesting from normal donorsC D Buckner, R A Clift, J E Sanders, et al.
Transplantation|November 1, 1983
Mycobacterial infections in marrow transplant patientsR M Navari, K M Sullivan, S C Springmeyer, et al.
Lancet (London, England)|September 18, 1982
Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantationR A Clift, C D Buckner, E D Thomas, et al.
Blood|April 15, 1991
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastomaR J Berenson, W I Bensinger, R S Hill, et al.
Bone Marrow Transplantation|March 1, 1997
Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II studyN Robinson, M C Benyunes, J A Thompson, et al.
Pageof 53